|
Post by jpg on Sept 22, 2014 23:47:53 GMT -5
It would seem there is meaningful upside from here even if one simply counted the upfront payments and product sales associated with the current capacity at Danbury. I am certainly a buyer at these levels. I've just now around $6 begun recommending it to people again as well, which is something I do less lightly than my own purchasing... friends and family recommendations that is, not just anonymous posts on boards. Lizard or human friends?
|
|
|
Post by daduke38 on Sept 23, 2014 6:22:45 GMT -5
The Lizard Fund has been accumulating today. I hope you aren't a tree lizard! They don't know where the bottom is either! But seriously, there's no rush to buy or reason so MNKD will continue to drop. (I have Jan '15 $10 options so it pains me to write that!) I have some of the same that I bought before the partnership. It also pains me as we would need as some of you like to call it "a White Swan" to save those. Never in my wildest imagination did I see a drop like this.
|
|
|
Post by cybergym66 on Sept 23, 2014 7:56:52 GMT -5
I hope you aren't a tree lizard! They don't know where the bottom is either! But seriously, there's no rush to buy or reason so MNKD will continue to drop. (I have Jan '15 $10 options so it pains me to write that!) I have some of the same that I bought before the partnership. It also pains me as we would need as some of you like to call it "a White Swan" to save those. Never in my wildest imagination did I see a drop like this. I was able to roll out of about half my Jan '15 $10 to the Jan '16 $10 but not before I took a big hit. Maybe after the HSR is approved MNKD/SNY will start filling in the details of the partnership and that will help the stock price recover. Not sure if $10 will be seen again before the Jan '15s expire but we'll see. Talk about SNY buying MNKD stock on the cheap and using their ADRs to swap with MNKD sound good...but we just can't bank on it happening.
|
|
|
Post by daduke38 on Sept 23, 2014 13:41:39 GMT -5
I have some of the same that I bought before the partnership. It also pains me as we would need as some of you like to call it "a White Swan" to save those. Never in my wildest imagination did I see a drop like this. I was able to roll out of about half my Jan '15 $10 to the Jan '16 $10 but not before I took a big hit. Maybe after the HSR is approved MNKD/SNY will start filling in the details of the partnership and that will help the stock price recover. Not sure if $10 will be seen again before the Jan '15s expire but we'll see. Talk about SNY buying MNKD stock on the cheap and using their ADRs to swap with MNKD sound good...but we just can't bank on it happening. Excuse my ignorance, but what is an ADR?
|
|
|
Post by dreamboatcruise on Sept 23, 2014 14:13:15 GMT -5
American Depository Receipt
It's when foreign shares are listed on American exchange. Sometimes there is a translation factor... such as 1 ADR representing 2 shares of the actual stock as traded on the foreign exchange.
|
|
|
Post by cybergym66 on Sept 23, 2014 17:20:45 GMT -5
American Depository Receipt It's when foreign shares are listed on American exchange. Sometimes there is a translation factor... such as 1 ADR representing 2 shares of the actual stock as traded on the foreign exchange. I *think* SNY has 500 Million shares (ADR) available if my poor memory is correct.
|
|
|
Post by daduke38 on Sept 23, 2014 19:06:15 GMT -5
American Depository Receipt It's when foreign shares are listed on American exchange. Sometimes there is a translation factor... such as 1 ADR representing 2 shares of the actual stock as traded on the foreign exchange. I *think* SNY has 500 Million shares (ADR) available if my poor memory is correct. Thanks for the answer. SNY does in fact have 500 million shares registered. I can't recall a link, but am positive of it. Wish they would use some and just buy us out ! If for no other reason than to stop the manipulation and burn every short in this stock! Would be such sweet poetic justice! I have been in the market for 30 years and this is the craziest stock I have ever owned. And it's not my first bio!
|
|
|
Post by mannmade on Sept 23, 2014 19:10:47 GMT -5
Yes it is 500m.
|
|
|
Post by cybergym66 on Sept 24, 2014 5:51:25 GMT -5
I *think* SNY has 500 Million shares (ADR) available if my poor memory is correct. Thanks for the answer. SNY does in fact have 500 million shares registered. I can't recall a link, but am positive of it. Wish they would use some and just buy us out ! If for no other reason than to stop the manipulation and burn every short in this stock! Would be such sweet poetic justice! I have been in the market for 30 years and this is the craziest stock I have ever owned. And it's not my first bio! Let's focus on getting past the HSR, then wait for details of the partnership (EOQ). When we hear that the new Danbury lines are finish and get production numbers then the Anal-yst will be able to come up with sales and profit projections. This could cause the stock to go up if the Anal-yst get their heads out of their "orifice" and realize Afrezza's sales potential and set price targets in the mid-teens. I know some analysts have set prices in that range but I don't think greedstreet has caught on yet.
|
|
|
Post by ezrasfund on Sept 24, 2014 18:40:42 GMT -5
I was going to say that 6.xx is the new 2.xx, and I did buy a few more $5 Jan '15. It is hard to believe that clearing HSR is a big surprise, but with $150 million in pocket it's doubtful the share price will keep dropping. Of course good news has had bad effects before.
|
|
|
Post by mnholdem on Sept 25, 2014 6:57:05 GMT -5
At this point, it might appear that the only news that will generate buying will be technical (ie sales figure, earnings). I've read MannKind shareholders described as a "cult". Is that a condemnation that long-time MNKD shareholders wear rose colored glasses or that the market is not as educated about the product?
The answer is important, I believe, because now that Sanofi can officially begin its marketing campaign to educate the industry and the market on the benefits of Afrezza, and as MannKind begins education related to Technosphere, will Wall Street and the wider market begin to see what the "cult" has understood for many years, the true potential of this company?
|
|
|
Post by pmikeks on Sept 25, 2014 8:40:28 GMT -5
I agree with you mnholdem and I believe Sanofi will do a very good job of educating the public (here and abroad) on the benefits and value of Afrezza. Think this means we will be happy with our investment in a year or so. If Mannkind puts forth some effort in educating the public and specifically the investment community on the value of Technosphere we will be elated with our investment. But they need to change their communication strategy if that's to happen.
I am very much a part of the 'Mannkind cult' if that's what it is and have been for about 5 years but I get very frustrated with their communication. Its amateurish, incomplete and often leaves more questions then answers. I think this is evident in the decline in share price every time they present at a medical conference. I'm sure having to settle a lawsuit some years back makes them cautious and guarded but they can do better or get somebody that can.
Hope we have reached the bottom and we are ready to begin our assent to more desirable levels.
|
|
|
Post by BlueCat on Sept 25, 2014 10:08:38 GMT -5
At this point, it might appear that the only news that will generate buying will be technical (ie sales figure, earnings). I've read MannKind shareholders described as a "cult". Is that a condemnation that long-time MNKD shareholders wear rose colored glasses or that the market is not as educated about the product? The answer is important, I believe, because now that Sanofi can officially begin its marketing campaign to educate the industry and the market on the benefits of Afrezza, and as MannKind begins education related to Technosphere, will Wall Street and the wider market begin to see what the "cult" has understood for many years, the true potential of this company? Rose-colored glasses. Right. Heard that one for sure. "hopium" vs. "DD" Another angle on this is on typical US business culture. A textbook conversation in business school, and often core to the reasoning for going private. Short-sighted. Budgets, staffing, planning, SP - seems to be heavily rooted on current financials, or projection for immediate upcoming quarter. In US businesses - the counter (or respin on this long term cultural trend) is that it supports 'agility' - not just for Agile development model, but business planning too - 'startup' culture seen as more successful. And thus the increased popularity too of day and swing trading over recommended long term investment strategies from Buffet, etc. So while I personally think the majority of this SP play is still with the MM and HFs and the manipulation on this via the SI, I think short-sighted retails and short-attention span media is at play in this too. Or at least being used by the players to support their cause. Play on fear - the further out the reward, the higher the risk .... just think of all the things that could go wrong ... and how long do you want dead money ... and so on.So - Essentially - once the shift in MNKD financials hits a current quarter with next quarter projections suggesting a heavy upswing - we may see the shift. It will simply be a lot harder for CNBC, analysts, etc to buck the basic business culture here and continue to pan it. I'm personally hoping this shift will start with Q3 reporting (per agreement, milestone payments and early projections from SNY based on their studies). But could easily take til Q4 or Q1 reporting pending the level of launch SNY spins up .... Until then - I hope we have bottom, but not confident on that. They will pounce on any opportunity that presents, and this news has not lifted the boat high enough yet to reverse the walk down damage they've done past couple.
|
|
|
Post by BlueCat on Sept 25, 2014 10:12:30 GMT -5
I agree with you mnholdem and I believe Sanofi will do a very good job of educating the public (here and abroad) on the benefits and value of Afrezza. Think this means we will be happy with our investment in a year or so. If Mannkind puts forth some effort in educating the public and specifically the investment community on the value of Technosphere we will be elated with our investment. But they need to change their communication strategy if that's to happen. I am very much a part of the 'Mannkind cult' if that's what it is and have been for about 5 years but I get very frustrated with their communication. Its amateurish, incomplete and often leaves more questions then answers. I think this is evident in the decline in share price every time they present at a medical conference. I'm sure having to settle a lawsuit some years back makes them cautious and guarded but they can do better or get somebody that can. Hope we have reached the bottom and we are ready to begin our assent to more desirable levels. I think what they've lost is that ability to sound like the brilliant 'startup' that they actually are. They've been in it a long time, and are now a public company. That makes it harder to maintain. But their presentation style is much more corporate, yet their business play is on innovation. They need (and have needed) a rockstar marketing person to own PR. Not a COO or CFO. Accounting or legal owning messaging and its delivery ... Just think on that.
|
|
|
Post by BlueCat on Sept 25, 2014 10:13:28 GMT -5
I know someone if they want to open that checkbook up ....
|
|